Showing results (1-10 of 258) with videos related to
Sort By:
Pageof 26
Advances in Experimental Medicine and Biology|March 22, 2017
Adverse Events in Cancer ImmunotherapyNoha Abdel-Wahab, Anas Alshawa, Maria E Suarez-AlmazorExpert Review of Clinical Immunology|February 24, 2024
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapyNoha Abdel-Wahab, Maria E Suarez-AlmazorRheumatology (Oxford, England)|December 10, 2019
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapyNoha Abdel-Wahab, Maria E Suarez-AlmazorCurrent Opinion in Rheumatology|March 15, 2019
Arthritis risk with immune checkpoint inhibitor therapy for cancerXerxes Pundole, Noha Abdel-Wahab, Maria E Suarez-AlmazorPlos One|July 30, 2016
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case ReportsNoha Abdel-Wahab, Mohsin Shah, Maria E Suarez-AlmazorSeminars in Arthritis and Rheumatism|June 19, 2018
Myositis as an adverse event of immune checkpoint blockade for cancer therapyMohsin Shah, Jean H Tayar, Noha Abdel-Wahab, et al.Annals of Internal Medicine|January 4, 2018
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic ReviewNoha Abdel-Wahab, Mohsin Shah, Maria A Lopez-Olivo, et al.ACR Open Rheumatology|March 6, 2026
Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune VasculitisJuan Sevillano, Noha Abdel-Wahab, Yixuan Zhou, et al.Plos One|June 21, 2019
A comprehensive scoping review to identify standards for the development of health information resources on the internetNoha Abdel-Wahab, Devesh Rai, Harish Siddhanamatha, et al.BMJ Oncology|January 31, 2025
Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitorsCarrie Ye, Bo Zhao, William D Leslie, et al.Pageof 26